In vivo studies have shown that KLF4 can modulate isoproterenol-induced cardiac hypertrophy by regulating myocardin (MYOCD) expression and activity, and cardiomyocyte-specific knockdown of KLF4 exacerbates hypertrophy (85). This evidence concerns the gene MYOCD and cardiac hypertrophy.